Patrick J. Marshalek, MD

Publications

2025

Drvar TB, Shychuck EM, Chhor B, Mayle L, Marshalek P, Zheng W. Managing Recurrent Endocarditis in Substance Use Disorder: The Role of Civil Commitment and Comprehensive Care. Am J Case Rep 2025;26:e945940. PMID: 39743768. PMCID: PMC11706431. DOI: 10.12659/AJCR.945940

2022

Warfield SC, Bharat C, Bossarte RM, DePhilippis D, Farrell M, Hoover M Jr, Larney S, Marshalek P, McKetin R, Degenhardt L. Trends in comorbid opioid and stimulant use disorders among Veterans receiving care from the Veterans Health Administration, 2005-2019. Drug Alcohol Depend 2022;232:109310. PMID: 35101816. DOI: 10.1016/j.drugalcdep.2022.109310

2021

Aboraya A, Nasrallah HA, Elswick D, Rastgar Y, Berry J, Hill C, Justice J, Zheng W, Pearson N, Gallucci G, Figgs P, Hustead J, Vogt J, Zafar J, Dohar S, Looper R, Guinan D, Elawady A, Shah O, Lam MW, Shagufta S, Schwartzman N, Hamric E, Mayle L, Miller M, Chandran D, Marshalek P, Moreland R, Tamang TL, Mattancheril S, Berzingi S. Measurement-based care training curriculum in psychiatry residency programs: I: Description of the curriculum and demonstration of implementation. Ann Clin Psychiatry 2021;33(3):168-179. PMID: 34398732. DOI: 10.12788/acp.0039

Kaski S, Marshalek P, Herschler J, Wen S, Zheng W. Sublingual buprenorphine/naloxone and multimodal management for high-risk chronic pain patients. Journal of Clinical Medicine 2021;10(5):973. PMID: 33801173. PMCID: PMC7957677. DOI: 10.3390/jcm10050973

Mahoney JJ, Winstanley EL, Lander LR, Berry JH, Marshalek PJ, Haut MW, Marton JL, Kimble WD, Armistead, Wen S, Cai Y, Hodder SL. High prevalence of co-occurring substance use in individuals with opioid use disorder. Addictive Behaviors 2021;114:106752. PMID: 33348147. DOI: 10.1016/j.addbeh.2020.106752

Pollini RA, Paquette CE, Drvar T, Marshalek P, Ang-Rabanes M, Feinberg J, Haut MW. A qualitative assessment of discharge against medical advice among patients hospitalized for injection-related bacterial infections in West Virginia. International Journal of Drug Policy 2021;94:103206. PMID: 33765516. DOI: 10.1016/j.drugpo.2021.103206

Tacker DH, Adelanwa A, Pearson N, Marshalek P, Berry JH. Fentanyl Quality Assurance Project Prompted Change in Clinical Workflow and Test Configurations. J Appl Lab Med 2021;6(1):93-100. PMID: 33276372. PMCID: PMC8415574. DOI: 10.1093/jalm/jfaa173

Publications Prior to 2021:

Zheng, W., Nickasch, M., Lander, L., Wen, S., Xiao, M., Marshalek, P., Dix, E, Sullivan, C. (2017). Treatment Outcome Comparison between Telepsychiatry and Face-to-face Buprenorphine Medication-Assisted Treatment (MAT) for Opioid Use Disorder: A 2-Year Retrospective Data Analysis. Journal of Addiction Medicine, 11(2), 138–144. http://doi.org/10.1097/ADM.0000000000000287

Nguyen L, Lander LR, O'Grady KE, Marshalek PJ, Schmidt A, Kelly AK, Jones HE. Treating women with opioid use disorder during pregnancy in Appalachia: Initial neonatal outcomes following buprenorphine + naloxone exposure. Am J Addict. 2018 Mar;27(2):92-96. doi: 10.1111/ajad.12687. Epub 2018 Feb 23. https://www.ncbi.nlm.nih.gov/pubmed/29473258

Wilson A, Marshalek P.  Drugs and Alcohol.  TRAUMA. Editors: Mattox KL, Moore EE, Feliciano DV.  McGraw-Hill, New York, NY. May 24, 2017 (ISBN 9781260128604)

Haut MW, Hogg JP, Marshalek PJ, Suter BC, Miller LE. Amnesia Associated with Bilateral Hippocampal and Bilateral Basal Ganglia Lesions in Anoxia with Stimulant Use. Front Neurol. 2017 Feb 8;8:27. doi: 10.3389/fneur.2017.00027. eCollection 2017. PMID: 28228745 https://www.ncbi.nlm.nih.gov/pubmed/28228745

Zheng W, Nickasch M, Lander L, Wen S, Xiao M, Marshalek P, Dix E, Sullivan C. Treatment Outcome Comparison Between Telepsychiatry and Face-to-face Buprenorphine Medication-assisted Treatment for Opioid Use Disorder: A 2-Year Retrospective Data Analysis. J Addict Med. 2017 Mar/Apr;11(2):138-144. doi: 10.1097/ADM.0000000000000287. PMID: 28107210

Shenai N, Glance J, Marshalek P. Special Interest Groups-Updates in Psychosomatics (SIG-UPs): Alcohol Use Disorders in Women. Psychosomatics. 2017 Jan - Feb;58(1):91-92. doi: 10.1016/j.psym.2016.08.008. Epub 2016 Aug 20. No abstract available. PMID: 28010750

Nguyen, L, Marshalek, P J, Weaver, C B, Cramer, K J, Pollard, SE, Matsumoto, RR. Off-label use of transmucosal ketamine as a rapid-acting antidepressant: a retrospective chart review. Neuropsychiatric Disease and Treatment. 2015; 11:2667-2673. doi: 10.2147/NDT. S88569. 

Lander L, Gurka K, Marshalek P, Riffon M, Sullivan R. Treatment of Pregnant Women With Opioid Use Disorders on Buprenorphine in Pregnancy-Only vs. Mixed-Gender Groups, submitted to SW Research, (2015) 39 (4): 235-244.